Trials / Conditions / Urothelial Carcinoma of the Bladder
Urothelial Carcinoma of the Bladder
4 registered clinical trials studyying Urothelial Carcinoma of the Bladder.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Active Not Recruiting | AN0025 and Pembrolizumab Combination in Advanced Solid Tumors NCT04432857 | Adlai Nortye Biopharma Co., Ltd. | Phase 1 |
| Active Not Recruiting | Risk Enabled Therapy After Initiating Neoadjuvant Chemotherapy for Bladder Cancer (RETAIN) NCT02710734 | Fox Chase Cancer Center | Phase 2 |
| Completed | Initial Evaluation of a Telomerase-based Circulating Tumor Cell Assay in Bladder Cancer Cohorts NCT02246738 | Abramson Cancer Center at Penn Medicine | — |
| Completed | Adjuvant Proton Therapy or IMRT for the Treatment of Bladder Cancer NCT01520038 | Abramson Cancer Center at Penn Medicine | Phase 1 / Phase 2 |